Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimal clinically important difference--exacerbations of COPD.

Peter M A Calverley1

  • 1Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. pmacal@liverpool.ac.uk

COPD
|December 2, 2006
PubMed
Summary

Defining clinically important differences in COPD exacerbation rates is challenging due to individual variability. However, interventions like pulmonary rehabilitation show promise in reducing exacerbation frequency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A journey of 1000 miles begins with a single step-proteomics, hyperinflation, and chronic obstructive pulmonary disease.

Annals of the American Thoracic Society·2026
Same author

Do You Believe in Magic? Computed Tomography, Artificial Intelligence, and Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2025
Same author

You can't always get what you want: evidence for exacerbation reduction with domiciliary oxygen therapy.

Thorax·2025
Same author

Lung Volumes in Smokers without Chronic Obstructive Pulmonary Disease: A Pointer to Disease Development?

Annals of the American Thoracic Society·2025
Same author

Still no room to breathe: insights on supine lung mechanics from oscillometry in COPD.

ERJ open research·2024
Same author

Taking your mind off breathlessness.

The European respiratory journal·2024

Area of Science:

  • Pulmonary Medicine
  • Clinical Epidemiology

Background:

  • Exacerbations of COPD are significant events that increase in frequency as the disease progresses.
  • Defining a minimum clinically important difference in exacerbation rate is difficult due to substantial between- and within-subject variability.
  • Current definitions often rely on seeking medical help rather than predefined symptom changes.

Purpose of the Study:

  • To explore the challenges in defining and measuring clinically important differences in COPD exacerbation rates.
  • To review the impact of interventions on exacerbation frequency.
  • To discuss the limitations of current methodologies for assessing clinically important differences in exacerbation outcomes.

Main Methods:

  • Review of existing literature on COPD exacerbations and intervention studies.

Related Experiment Videos

  • Analysis of the relationship between symptom improvement (St George's Respiratory Questionnaire) and exacerbation reduction.
  • Discussion of methodological challenges in applying standard statistical approaches to binary outcomes like exacerbations.

    • Main Results:

    • Interventions including bronchodilators, inhaled corticosteroids, and pulmonary rehabilitation appear to reduce exacerbation frequency.
    • In patients with FEV1 < 50% predicted, a 4-unit improvement in St George's Respiratory Questionnaire correlates with a 20-25% reduction in reported exacerbations.
    • Existing methods for estimating clinically important differences are difficult to apply to binary outcomes.

    Conclusions:

    • Establishing a minimum clinically important difference for COPD exacerbation rates remains problematic.
    • Symptomatic benefit may indicate a clinically important change in exacerbations, but this requires prospective validation.
    • Further research is needed to develop robust methods for assessing clinically important differences in COPD exacerbation rates.